Trust Company of Vermont’s iShares Biotechnology ETF IBB Stock Holding History

Trust Company of Vermont’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$26.2K	Hold	155	–	–	﹤0.01%	697
2025 Q3	$22.4K	Buy	+155	New	+$21.2K	﹤0.01%	721
2024 Q4	–	Sell	-569	Closed	-$82.8K	–	1084
2024 Q3	$82.8K	Sell	569 -100	-15%	-$14.5K	﹤0.01%	436
2024 Q2	$91.8K	Hold	669	–	–	0.01%	413
2024 Q1	$91.8K	Buy	669 +344	+106%	+$47K	0.01%	399
2023 Q4	$44.2K	Hold	325	–	–	﹤0.01%	444
2023 Q3	$39.7K	Hold	325	–	–	﹤0.01%	475
2023 Q2	$41.3K	Sell	325 -200	-38%	-$26K	﹤0.01%	503
2023 Q1	$67.8K	Sell	525 -102	-16%	-$13.4K	﹤0.01%	447
2022 Q4	$82.3K	Buy	627 +102	+19%	+$13.2K	0.01%	414
2022 Q3	$61K	Hold	525	–	–	﹤0.01%	459
2022 Q2	$62K	Buy	+525	New	+$62.3K	﹤0.01%	450
2022 Q1	–	Sell	-745	Closed	-$114K	–	511
2021 Q4	$114K	Buy	+745	New	+$115K	0.01%	379
2021 Q3	–	Sell	-745	Closed	-$122K	–	496
2021 Q2	$122K	Sell	745 -140	-16%	-$21.6K	0.01%	367
2021 Q1	$133K	Buy	885 +360	+69%	+$57.2K	0.01%	345
2020 Q4	$80K	Hold	525	–	–	0.01%	403
2020 Q3	$71K	Hold	525	–	–	0.01%	404
2020 Q2	$72K	Buy	525 +225	+75%	+$28.7K	0.01%	398
2020 Q1	$32K	Hold	300	–	–	﹤0.01%	497
2019 Q4	$36K	Hold	300	–	–	﹤0.01%	519
2019 Q3	$30K	Hold	300	–	–	﹤0.01%	561
2019 Q2	$33K	Hold	300	–	–	﹤0.01%	537
2019 Q1	$34K	Hold	300	–	–	﹤0.01%	528
2018 Q4	$29K	Hold	300	–	–	﹤0.01%	549
2018 Q3	$37K	Hold	300	–	–	﹤0.01%	564
2018 Q2	$33K	Sell	300 -939	-76%	-$100K	﹤0.01%	594
2018 Q1	$132K	Buy	1,239 +384	+45%	+$42.6K	0.01%	362
2017 Q4	$91K	Hold	855	–	–	0.01%	411
2017 Q3	$95K	Hold	855	–	–	0.01%	409
2017 Q2	$88K	Hold	855	–	–	0.01%	426
2017 Q1	$83K	Hold	855	–	–	0.01%	426
2016 Q4	$76K	Hold	855	–	–	0.01%	425
2016 Q3	$83K	Hold	855	–	–	0.01%	369
2016 Q2	$74K	Hold	855	–	–	0.01%	352
2016 Q1	$74K	Hold	855	–	–	0.01%	347
2015 Q4	$96K	Buy	855 +90	+12%	+$9.77K	0.01%	319
2015 Q3	$77K	Buy	765 +375	+96%	+$45K	0.01%	338
2015 Q2	$48K	Buy	390 +30	+8%	+$3.59K	0.01%	408
2015 Q1	$41K	Buy	360 +30	+9%	+$3.31K	0.01%	428
2014 Q4	$33K	Buy	330 +30	+10%	+$2.92K	﹤0.01%	465
2014 Q3	$27K	Hold	300	–	–	﹤0.01%	494
2014 Q2	$26K	Hold	300	–	–	﹤0.01%	479
2014 Q1	$24K	Buy	+300	New	+$25K	﹤0.01%	486

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Trust Company of Vermont's IBB Position: Q4 2025 in Review

Trust Company of Vermont held its iShares Biotechnology ETF (IBB) position steady in Q4 2025 at 155 shares worth $26.2K. The position accounts for ﹤0.01% of the portfolio, ranked #697.

Trust Company of Vermont first reported a position in IBB in Q1 2014 and has held it in 43 quarters since. The position peaked at $133K in Q1 2021. 956 funds tracked by Wall St. Rank hold IBB as of Q4 2025.

Trust Company of Vermont held 155 shares of iShares Biotechnology ETF worth $26.2K as of Q4 2025.
Trust Company of Vermont left its iShares Biotechnology ETF share count unchanged in Q4 2025.
iShares Biotechnology ETF made up ﹤0.01% of Trust Company of Vermont's portfolio in Q4 2025, its #697 holding.
Trust Company of Vermont first reported a position in iShares Biotechnology ETF in Q1 2014 and has held it in 43 quarters since.
Trust Company of Vermont's iShares Biotechnology ETF position peaked at $133K in Q1 2021.
956 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2025.

Based on Trust Company of Vermont's 13F filing for Q4 2025, filed 16 Jan 2026.